Abstract:To establish a persistent infection mouse model and study its immunological characteristics ,female C57BL/6 mice were infected with Mycobacterium tuberculosis (M . tuberculosis) H37Rv at a dose of 1 × 105 CFU/mouse by tail vein injection .Four weeks after infection ,the mice in the chemotherapy group were treated with isoniazid and rifampicin in drinking water for 8 weeks .At 4 ,8 and 12 weeks after infection ,6 mice from each study group were euthanized to examine bacterial burden in the lungs and spleens . The homogenized organs were serially diluted and plated on plates for bacterial count after 21-day incubation . Mouse sera were collected and the total anti-M . tuberculosis IgG and its subclasses were analyzed by enzyme-linked immunosorbent assay (ELISA ) . CD4+ splenocytes were cultured with purified protein derivative (PPD) stimulation ,and the percentages of interferon γ(IFN-γ) ,interleukin 2 (IL-2) ,IL-4 ,and tumor necrosis factor α (TNF-α) expressing cells were then identified by intracellular cytokine staining and flow cytometry .The results showed that the lgCFU of bacterial loads in lungs and spleens reached to 3 .67 ± 0 .25 and 3 .54 ± 0 .24 ,respectively 4 weeks after infection and the level retained for at least 8 weeks .The chemotherapy reduced the bacterial loads in organs significantly .12 weeks after infection ,M . tuberculosis specific total IgG level increased significantly in the untreated group ( P< 0 .01 ) , especially IgG1 ( P<0 .01) .The IgG level in the chemotherapy group also increased (P<0 .05) but at a pace slower than that in the untreated group (P<0 .01) .Compared with the untreated group ,the chemotherapy group had a lower IgG1 level (P<0 .01) but a higher IgG2a level (P<0 .05) .The untreated group had a significantly higher percentage of IFN-γ and IL-2 expressing CD4+ splenocytes (P<0 .01 ,P<0 .001) and lower percentage of IL-4 expressing CD4+ splenocytes compared with the control group (P<0 .01) .The percentages of IL-2 and IL-4 expressing CD4+ splenocytes were both lower after chemotherapy compared with the naive group ( P<0 .05 , P<0 .01 ) . A persistent infection mouse model of M . tuberculosis was established , and its immunological characteristics were identified in the study .It may provide certain applications in new vaccine and drug screening study against tuberculosis .

The value of micro-CT in monitoring the dynamic evolution of acute pulmonary tuberculosis in mice

Establishment and Comprehensive Evaluation of a Mouse Model of Tuberculosis Induced by Aerosol Infection

Experimental Research of the Relationship Between Lung Pathological Changes and Cell Immunity of Tuberculosis Infection

Progression and Dissemination of Pulmonary Mycobacterium Avium Infection in a Susceptible Immunocompetent Mouse Model

Establishment of a mouse model for Mycobacterium tuberculosis persistent infection and its immunological characteristics

Immunopathology of Pulmonary Mycobacterium tuberculosis Infection in a Humanized Mouse Model

Comparison of acute Mycobacterium tuberculosis infection mouse models established by different infection routes

[Molecular markers of M. tuberculosis virulence in lung tissue (experimental study)]

The inflammatory response and T lymphocytes with SLAM expression in macrophages of mice infected with mycobacterium tuberculosis

The Pathogen Isolation of Mycobacterium Tuberculosis and Identification of Infectious Disease Mechanism in Mice

Micro-computed tomography imaging of cigarette smoke-exposed mice to model early chronic obstructive pulmonary disease (COPD)

A New Model of Chronic Mycobacterium abscessus Lung Infection in Immunocompetent Mice

The Dynamic Changes of Tuberculosis Related Cytokines During Disease Progression

A mouse model of TB-associated lung fibrosis reveals persistent inflammatory macrophage populations during treatment

Efficient Tuberculosis Treatment in Mice Using Chemotherapy and Immunotherapy with the Combined DNA Vaccine Encoding Ag85B, MPT-64 and MPT-83

Identification of a Diagnostic Multiomics-Based Biomarker Cluster in a Mouse Model of Pulmonary Tuberculosis

Longitudinal assessment of bleomycin-induced lung fibrosis by Micro-CT correlates with histological evaluation in mice

A Mouse Model for Tuberculosis Combined With Inhalable Imiquimod-PLGA Nanocomposite Particles Based on Macrophage Phenotype

Mycobacterium tuberculosis ESX-T7SS impacts the 3D architecture of tuberculous lesion in susceptible mice

The Significance of T Cell Subsets on the Peripheral Blood of Tuberculosis Infection Mice

The frequency of CD38+ alveolar macrophages correlates with early control of M. tuberculosis in the murine lung